NASDAQ:XENE - Xenon Pharmaceuticals News Headlines

Sign in or create an account to add this stock to your watchlist.
$7.84 +0.12 (+1.55 %)
(As of 02/22/2019 04:00 PM ET)
Previous Close$7.84
Today's Range$7.58 - $7.84
52-Week Range$3.60 - $15.92
Volume28,372 shs
Average Volume65,253 shs
Market Capitalization$197.88 million
P/E Ratio-4.56
Dividend YieldN/A
Beta1.72

Headlines

Xenon Pharmaceuticals (NASDAQ XENE) News Headlines

Source:
DateHeadline
-$0.37 Earnings Per Share Expected for Xenon Pharmaceuticals Inc (XENE) This Quarter-$0.37 Earnings Per Share Expected for Xenon Pharmaceuticals Inc (XENE) This Quarter
www.americanbankingnews.com - February 13 at 9:12 PM
Xenon updates on two CNS pipeline candidates; shares up 2%Xenon updates on two CNS pipeline candidates; shares up 2%
seekingalpha.com - January 28 at 6:20 PM
Xenon Provides Key Regulatory Updates on XEN007 and XEN1101Xenon Provides Key Regulatory Updates on XEN007 and XEN1101
finance.yahoo.com - January 28 at 8:18 AM
What Kind Of Shareholder Owns Most Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Stock? - Yahoo Finance UKWhat Kind Of Shareholder Owns Most Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Stock? - Yahoo Finance UK
uk.finance.yahoo.com - January 20 at 8:19 AM
What Kind Of Shareholder Owns Most Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Stock?What Kind Of Shareholder Owns Most Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Stock?
finance.yahoo.com - January 18 at 5:43 PM
Xenon Pharmaceuticals Outlines 2019 Key MilestonesXenon Pharmaceuticals Outlines 2019 Key Milestones
finance.yahoo.com - January 7 at 8:16 AM
Xenon Announces Final Results of XEN1101 Phase 1 Clinical Trial and Update on XEN901 Phase 1 Clinical Trial at the American Epilepsy Society (AES) Annual MeetingXenon Announces Final Results of XEN1101 Phase 1 Clinical Trial and Update on XEN901 Phase 1 Clinical Trial at the American Epilepsy Society (AES) Annual Meeting
finance.yahoo.com - December 3 at 8:20 AM
Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update and Overview of Presentations at the 2018 American Epilepsy Society (AES) MeetingXenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update and Overview of Presentations at the 2018 American Epilepsy Society (AES) Meeting
finance.yahoo.com - November 30 at 5:52 PM
Is Xenon Pharmaceuticals Inc (NASDAQ:XENE) Overpaying Its CEO?Is Xenon Pharmaceuticals Inc (NASDAQ:XENE) Overpaying Its CEO?
finance.yahoo.com - November 15 at 5:25 PM
Investor Expectations to Drive Momentum within The York Water, Canon, Peak Resorts, Volt Information Sciences, LSI Industries, and Xenon Pharmaceuticals — Discovering Underlying Factors of InfluenceInvestor Expectations to Drive Momentum within The York Water, Canon, Peak Resorts, Volt Information Sciences, LSI Industries, and Xenon Pharmaceuticals — Discovering Underlying Factors of Influence
finance.yahoo.com - November 15 at 8:21 AM
Xenon Pharmaceuticals, Inc. (XENE) CEO Simon Pimstone on Q3 2018 Results - Earnings Call TranscriptXenon Pharmaceuticals, Inc. (XENE) CEO Simon Pimstone on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 10 at 5:30 PM
Xenon Pharmaceuticals to Present at the Stifel 2018 Healthcare ConferenceXenon Pharmaceuticals to Present at the Stifel 2018 Healthcare Conference
finance.yahoo.com - November 7 at 5:46 PM
Xenon Pharmaceuticals: 3Q Earnings SnapshotXenon Pharmaceuticals: 3Q Earnings Snapshot
finance.yahoo.com - November 7 at 8:21 AM
Edited Transcript of XENE earnings conference call or presentation 6-Nov-18 9:30pm GMTEdited Transcript of XENE earnings conference call or presentation 6-Nov-18 9:30pm GMT
finance.yahoo.com - November 7 at 8:21 AM
Xenon Pharma misses by $0.18Xenon Pharma misses by $0.18
seekingalpha.com - November 6 at 5:32 PM
Xenon Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate UpdateXenon Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - November 6 at 5:32 PM
Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2018 Financial Results and Provide Corporate UpdateXenon Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2018 Financial Results and Provide Corporate Update
finance.yahoo.com - October 30 at 5:32 PM
Xenon Pharma closes $63M stock offeringXenon Pharma closes $63M stock offering
seekingalpha.com - September 17 at 5:17 PM
Xenon Pharmaceuticals Announces Closing of its $63.0 Million Public Offering of Common SharesXenon Pharmaceuticals Announces Closing of its $63.0 Million Public Offering of Common Shares
finance.yahoo.com - September 17 at 5:17 PM
Xenon Pharmaceuticals (XENE) Announces Proposed Public Offering of Common SharesXenon Pharmaceuticals (XENE) Announces Proposed Public Offering of Common Shares
www.streetinsider.com - September 13 at 4:53 PM
Xenon Pharmaceuticals prices $63M public offering of common sharesXenon Pharmaceuticals prices $63M public offering of common shares
seekingalpha.com - September 13 at 4:53 PM
Form 8-K Xenon Pharmaceuticals For: Sep 12Form 8-K Xenon Pharmaceuticals For: Sep 12
www.streetinsider.com - September 13 at 8:27 AM
Xenon Pharmaceuticals (XENE) to Acquire XEN1101 Milestones and Royalties from Bausch Health (BHC)Xenon Pharmaceuticals (XENE) to Acquire XEN1101 Milestones and Royalties from Bausch Health (BHC)
www.streetinsider.com - September 12 at 8:20 AM
Xenon Enters into Agreement to Buy Out Milestones and Royalties Related to its XEN1101 ProgramXenon Enters into Agreement to Buy Out Milestones and Royalties Related to its XEN1101 Program
finance.yahoo.com - September 11 at 8:24 AM
Xenon: An Updated Investment AnalysisXenon: An Updated Investment Analysis
seekingalpha.com - September 10 at 4:56 PM
Is Xenon Pharmaceuticals A Stock To Consider?Is Xenon Pharmaceuticals A Stock To Consider?
seekingalpha.com - September 8 at 8:18 AM
Xenon Pharma up 15% on new pipeline candidateXenon Pharma up 15% on new pipeline candidate
seekingalpha.com - September 7 at 5:06 PM
Xenon expands ion channel neurology pipeline with addition of XEN496 for the treatment of epilepsyXenon expands ion channel neurology pipeline with addition of XEN496 for the treatment of epilepsy
seekingalpha.com - September 6 at 8:26 AM
Xenon Pharmaceuticals (XENE) Plans XEN496 Pivotal Phase 3 Trial in mid-2019Xenon Pharmaceuticals (XENE) Plans XEN496 Pivotal Phase 3 Trial in mid-2019
www.streetinsider.com - September 6 at 8:26 AM
Xenon Expands Ion Channel Neurology Pipeline with Addition of XEN496, a “Phase 3 Ready” Potassium Channel Modulator for the Treatment of EpilepsyXenon Expands Ion Channel Neurology Pipeline with Addition of XEN496, a “Phase 3 Ready” Potassium Channel Modulator for the Treatment of Epilepsy
finance.yahoo.com - September 6 at 8:26 AM
Xenon Expands Ion Channel Neurology Pipeline with Addition of XEN496, a "Phase 3 Ready" Potassium Channel Modulator for the Treatment of EpilepsyXenon Expands Ion Channel Neurology Pipeline with Addition of XEN496, a "Phase 3 Ready" Potassium Channel Modulator for the Treatment of Epilepsy
feeds.benzinga.com - September 6 at 7:44 AM
Xenon Pharmaceuticals (XENE) Provides Financial Support For The Study Of The New Antiepileptic Drug XEN1101 - SlideshowXenon Pharmaceuticals (XENE) Provides Financial Support For The Study Of The New Antiepileptic Drug XEN1101 - Slideshow
seekingalpha.com - August 29 at 4:58 PM
Edited Transcript of XENE earnings conference call or presentation 7-Aug-18 8:30pm GMTEdited Transcript of XENE earnings conference call or presentation 7-Aug-18 8:30pm GMT
finance.yahoo.com - August 19 at 8:29 AM
Xenon Pharmaceuticals, Inc. (XENE) CEO Dr. Simon Pimstone on Q2 2018 Results - Earnings Call TranscriptXenon Pharmaceuticals, Inc. (XENE) CEO Dr. Simon Pimstone on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 11 at 5:06 PM
Xenon Pharmaceuticals: 2Q Earnings SnapshotXenon Pharmaceuticals: 2Q Earnings Snapshot
finance.yahoo.com - August 8 at 8:26 AM
Xenon Pharmaceuticals (XENE) Reports Q2 Loss, Misses Revenue EstimatesXenon Pharmaceuticals (XENE) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 8 at 8:26 AM
Xenon Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate UpdateXenon Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - August 7 at 5:24 PM
Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2018 Financial Results and Provide Corporate UpdateXenon Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2018 Financial Results and Provide Corporate Update
finance.yahoo.com - August 3 at 4:31 PM
Xenon Pharma inks $50M stock sales agreementXenon Pharma inks $50M stock sales agreement
seekingalpha.com - July 12 at 8:19 AM
Xenon Pharmaceuticals Announces At-The-Market Equity OfferingXenon Pharmaceuticals Announces At-The-Market Equity Offering
finance.yahoo.com - July 12 at 8:19 AM
A Look At Biotech In 2018 And The Biggest Catalysts Coming Up In The Second Half Of The YearA Look At Biotech In 2018 And The Biggest Catalysts Coming Up In The Second Half Of The Year
feeds.benzinga.com - July 5 at 1:34 PM
Form SC 13G Xenon Pharmaceuticals Filed by: ADAGE CAPITAL PARTNERS GP, LLCForm SC 13G Xenon Pharmaceuticals Filed by: ADAGE CAPITAL PARTNERS GP, LLC
www.streetinsider.com - July 3 at 5:08 PM
Xenon Pharma +3.9% as Potiga gets orphan drug statusXenon Pharma +3.9% as Potiga gets orphan drug status
seekingalpha.com - June 25 at 5:37 PM
Benzingas Daily Biotech Pulse: vTv Swoons On Failed Alzheimers Trial, Regenxbio Gets FDA Fast Track For RGX-111Benzinga's Daily Biotech Pulse: vTv Swoons On Failed Alzheimer's Trial, Regenxbio Gets FDA Fast Track For RGX-111
feeds.benzinga.com - June 13 at 8:20 AM
Xenon Pharma continues northward march, up 15%Xenon Pharma continues northward march, up 15%
seekingalpha.com - June 12 at 5:03 PM
41 Stocks Moving In Tuesdays Mid-Day Session41 Stocks Moving In Tuesday's Mid-Day Session
feeds.benzinga.com - June 12 at 1:20 PM
Xenon Pharmaceuticals to Present at the Jefferies 2018 Healthcare ConferenceXenon Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference
finance.yahoo.com - June 1 at 5:43 PM
Reader Inquiry: Can The Run Up Continue For Xenon Pharmaceuticals?Reader Inquiry: Can The Run Up Continue For Xenon Pharmaceuticals?
seekingalpha.com - May 30 at 5:19 PM
Blog Exposure - Xenon Announced Presentation of Positive XEN1101 TMS Pharmacodynamic Phase-1 Data at 14th Eilat ConferenceBlog Exposure - Xenon Announced Presentation of Positive XEN1101 TMS Pharmacodynamic Phase-1 Data at 14th Eilat Conference
finance.yahoo.com - May 17 at 8:24 AM
Xenon Pharma (XENE) Presents XEN1101 Interim Phase 1 Data At 14th Eilat Conference - SlideshowXenon Pharma (XENE) Presents XEN1101 Interim Phase 1 Data At 14th Eilat Conference - Slideshow
seekingalpha.com - May 16 at 5:40 PM
This page was last updated on 2/23/2019 by MarketBeat.com Staff

Featured Article: Is the QQQ ETF safe?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel